Detalhe da pesquisa
1.
A macaque clonal hematopoiesis model demonstrates expansion of TET2-disrupted clones and utility for testing interventions.
Blood
; 140(16): 1774-1789, 2022 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35714307
2.
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes.
N Engl J Med
; 382(2): 140-151, 2020 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31914241
3.
Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33/CD3 T cell engager, ex vivo in MDS and melanoma.
Mol Ther
; 30(6): 2315-2326, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35150889
4.
Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic Syndromes.
Int J Mol Sci
; 24(4)2023 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36835307
5.
TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype.
Blood
; 136(24): 2812-2823, 2020 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32730593
6.
Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML.
Blood
; 130(4): 397-407, 2017 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28576879
7.
Genetically inspired prognostic scoring system (GIPSS) outperforms dynamic international prognostic scoring system (DIPSS) in myelofibrosis patients.
Am J Hematol
; 94(1): 87-92, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30390311
8.
When clinical heterogeneity exceeds genetic heterogeneity: thinking outside the genomic box in chronic myelomonocytic leukemia.
Blood
; 128(20): 2381-2387, 2016 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27707735
9.
The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype.
Blood
; 128(25): 2960-2975, 2016 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27737891
10.
Between a rux and a hard place: evaluating salvage treatment and outcomes in myelofibrosis after ruxolitinib discontinuation.
Ann Hematol
; 97(3): 435-441, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29189896
11.
The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes.
Ann Hematol
; 97(2): 247-254, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29167940
12.
Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromes.
Proc Natl Acad Sci U S A
; 112(46): E6359-68, 2015 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26578796
13.
Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study.
Lancet Oncol
; 18(1): 112-121, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27927582
14.
An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults.
Blood
; 125(12): 1857-65, 2015 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25624319
15.
Phase 1 study of lenzilumab, a recombinant anti-human GM-CSF antibody, for chronic myelomonocytic leukemia.
Blood
; 136(7): 909-913, 2020 08 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32294158
16.
Dual pyroptotic biomarkers predict erythroid response in lower-risk non-del(5q) myelodysplastic syndromes treated with lenalidomide and recombinant erythropoietin.
Haematologica
; 107(3): 737-739, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320786
17.
Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double-induction chemotherapy: Analysis from a large, single institution experience.
Am J Hematol
; 92(3): 232-237, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28006850
18.
Aberrant overexpression of CD14 on granulocytes sensitizes the innate immune response in mDia1 heterozygous del(5q) MDS.
Blood
; 124(5): 780-90, 2014 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-24891322
19.
Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS).
Haematologica
; 101(6): 781-8, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26944474
20.
Autoimmune diseases and myelodysplastic syndromes.
Am J Hematol
; 91(5): E280-3, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26875020